231.41USD-0.40%Mkt Cap: 11.98B USDP/E: —Last update: 2026-06-01
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap11.98B USD
Enterprise Value11.98B USD
Revenue (TTM)708.24M USD
Gross Profit591.02M USD
Net Income (TTM)-183.17M USD
Revenue/Share14.07 USD
Last Price231.41 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS05464T1043
Valuation
P/E (Trailing)—
P/E (Forward)39.83
PEG—
EV/EBITDA-71.64
EV/Revenue16.92
P/S17.04
P/B220.79
EPS (TTM)-3.73
EPS (Forward)5.89
52W Range
96.0995% of range238.56
52W High238.56 USD
52W Low96.09 USD
Profitability
Gross Margin92.56%
Oper. Margin-32.83%
EBITDA Margin-23.61%
Profit Margin-28.69%
ROE-207.46%
ROA-26.55%
Growth
Revenue Growth57.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-93.41M USD
CapEx (TTM)480.00K USD
FCF Margin-0.54%
FCF Yield-0.03%
Net Debt-85.21M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity2.47
Current Ratio1.39
Quick Ratio1.27
Book Value/Sh1.062 USD
Cash/Share5.929 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)270.28 USD
Target Range200.00 USD – 328.81 USD
# Analysts21
Ownership
Shares Out.51.46M
Float43.55M
Insiders15.38%
Institutions76.73%
Short Interest
Short Ratio3.2d
Short % Float8.45%
Short % Out.5.40%
Shares Short2.78M
Short (prev mo.)2.68M
Technical
SMA 50194.52 (+19.0%)
SMA 200158.65 (+45.9%)
Beta0.58
S&P 52W Chg27.94%
Avg Vol (30d)774.69K
Avg Vol (10d)583.64K
Technical Indicators
RSI (14)67.4
MACD10.9664
MACD Signal12.0163
MACD Hist.-1.0498
BB Upper242.74 USD
BB Middle227.03 USD
BB Lower211.32 USD
BB Width13.84%
ATR (14)7.435 USD
Vol Ratio (20d)0.53x